The medications used here are the same ones used elsewhere — delivered intravenously or as a nasal spray. What differs is how treatment is carried out, and by whom.

Getting the dose right from the outset is the foundation of effective ketamine treatment. Standard weight-based protocols are a starting point. However, consideration of body composition, ideal body weight, and genetic information allows us to better anticipate an individual's drug level and clinical response before treatment even begins.

Once treatment begins, clinical response becomes the guiding principle. This requires not only familiarity with ketamine but a working knowledge of the conditions being treated and an understanding of what meaningful progress looks like as it unfolds.

That same attention to dose and response carries into individual sessions, and for every intravenous treatment, the physician is present at bedside for the duration. Each session is observed firsthand — medically and psychiatrically — and dosing adjustments are made in real time.

This expertise is brought to bear regardless of whether you are establishing care here or are referred solely for ketamine treatment. In either case, our role is to administer ketamine with the same clinical precision and psychiatric understanding.

⸻

Intravenous ketamine is often preferred when a faster onset of effect is desired or when a more structured and closely guided treatment is beneficial.

Intranasal ketamine is administered as a nasal spray and avoids IV placement. Sessions are typically longer and less intensive, and this approach suits patients who prefer a less invasive option or a more gradual treatment course.

⸻

When ketamine is appropriate, treatment here is designed to begin without unnecessary delay. Initial evaluations are typically available within a short timeframe, and treatment often begins within one to two weeks — sooner when clinically indicated.